Todd Asset Management LLC Raises Stock Holdings in Smith & Nephew SNATS, Inc. $SNN

Todd Asset Management LLC raised its position in Smith & Nephew SNATS, Inc. (NYSE:SNN) by 30.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 944,578 shares of the medical equipment provider’s stock after buying an additional 219,348 shares during the quarter. Todd Asset Management LLC’s holdings in Smith & Nephew SNATS were worth $30,992,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also modified their holdings of the stock. Goldman Sachs Group Inc. increased its holdings in shares of Smith & Nephew SNATS by 49.2% in the first quarter. Goldman Sachs Group Inc. now owns 1,771,401 shares of the medical equipment provider’s stock valued at $50,255,000 after purchasing an additional 583,809 shares during the period. Bank of America Corp DE grew its position in Smith & Nephew SNATS by 139.9% in the 3rd quarter. Bank of America Corp DE now owns 987,274 shares of the medical equipment provider’s stock valued at $35,828,000 after buying an additional 575,666 shares during the last quarter. BNP Paribas Financial Markets grew its position in Smith & Nephew SNATS by 45.5% in the 3rd quarter. BNP Paribas Financial Markets now owns 937,943 shares of the medical equipment provider’s stock valued at $34,038,000 after buying an additional 293,418 shares during the last quarter. ABC Arbitrage SA grew its position in Smith & Nephew SNATS by 10.9% in the 4th quarter. ABC Arbitrage SA now owns 757,956 shares of the medical equipment provider’s stock valued at $24,869,000 after buying an additional 74,504 shares during the last quarter. Finally, Teachers Retirement System of The State of Kentucky grew its position in Smith & Nephew SNATS by 31.8% in the 4th quarter. Teachers Retirement System of The State of Kentucky now owns 599,500 shares of the medical equipment provider’s stock valued at $19,670,000 after buying an additional 144,800 shares during the last quarter. Institutional investors and hedge funds own 25.64% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have commented on SNN shares. Canaccord Genuity Group cut their price objective on shares of Smith & Nephew SNATS from $32.00 to $30.00 and set a “hold” rating for the company in a research report on Monday, May 11th. Sanford C. Bernstein set a $31.85 price objective on shares of Smith & Nephew SNATS in a research report on Monday, May 11th. The Goldman Sachs Group restated a “buy” rating on shares of Smith & Nephew SNATS in a research report on Monday. Weiss Ratings restated a “hold (c+)” rating on shares of Smith & Nephew SNATS in a research report on Monday, April 20th. Finally, Wall Street Zen downgraded shares of Smith & Nephew SNATS from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 9th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $30.93.

Smith & Nephew SNATS Trading Down 0.1%

NYSE:SNN opened at $30.51 on Monday. The stock has a fifty day moving average price of $31.91 and a two-hundred day moving average price of $33.16. The company has a current ratio of 2.57, a quick ratio of 1.25 and a debt-to-equity ratio of 0.60. Smith & Nephew SNATS, Inc. has a 1 year low of $28.33 and a 1 year high of $38.79.

Smith & Nephew SNATS (NYSE:SNN) last released its quarterly earnings data on Tuesday, February 17th. The medical equipment provider reported $29.55 earnings per share (EPS) for the quarter. The business had revenue of $1.60 billion during the quarter. As a group, equities research analysts forecast that Smith & Nephew SNATS, Inc. will post 2.25 earnings per share for the current fiscal year.

Smith & Nephew SNATS Dividend Announcement

The firm also recently disclosed a dividend, which will be paid on Wednesday, May 27th. Shareholders of record on Friday, March 27th will be given a $0.482 dividend. The ex-dividend date is Friday, March 27th. This represents a yield of 304.0%.

About Smith & Nephew SNATS

Smith & Nephew plc is a global medical technology company specializing in the design, development and manufacture of advanced surgical devices, orthopaedic reconstruction implants, trauma and extremities products, sports medicine solutions and wound care therapies. Founded in 1856 in Hull, United Kingdom, the company has grown through both organic innovation and strategic acquisitions to offer a broad portfolio that addresses patient needs across joint replacement, minimally invasive surgery and wound healing.

In its orthopaedics business, Smith & Nephew provides hip and knee replacement systems, modular joint revision implants and biologic solutions for bone repair.